Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean F Bajorin

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology|August 18, 2015
Genomic Characterization of Upper Tract Urothelial CarcinomaJohn P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
The New England Journal of Medicine|June 2, 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial CarcinomaDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Future Oncology (London, England)|March 15, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summaryDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder CancerEugene J Pietzak, Karissa Whiting, Preethi Srinivasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Nature Immunology|July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccineRamin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Clinical Genitourinary Cancer|June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant ChemotherapyMin Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology|August 18, 2015
Genomic Characterization of Upper Tract Urothelial CarcinomaJohn P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
The New England Journal of Medicine|June 2, 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial CarcinomaDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Future Oncology (London, England)|March 15, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summaryDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder CancerEugene J Pietzak, Karissa Whiting, Preethi Srinivasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Nature Immunology|July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccineRamin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Clinical Genitourinary Cancer|June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant ChemotherapyMin Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
Pageof 17